Oramed Pharmaceuticals
ORMP
#9076
Rank
A$0.27 B
Marketcap
A$6.74
Share price
0.21%
Change (1 day)
101.25%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): A$0.11 Billion

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of A$0.10 Billion, an increase over its 2024 earnings that were of -A$21.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.11 B9.51%
2025 A$0.10 B-616.9%
2024 -A$21.07 Million-311.47%
2023 A$9.96 M-119.45%
2022 -A$51.21 Million39.17%
2021 -A$36.8 Million73.93%
2020 -A$21.16 Million18.53%
2019 -A$17.85 Million-16.62%
2018 -A$21.41 Million38.32%
2017 -A$15.48 Million12.51%
2016 -A$13.76 Million25.01%
2015 -A$11.01 Million18.18%
2014 -A$9.32 Million39.72%
2013 -A$6.67 Million46.4%
2012 -A$4.56 Million128.32%
2011 -A$2 Million-51.47%
2010 -A$4.11 Million35.21%
2009 -A$3.04 Million
2007 -A$4.78 Million607.04%
2006 -A$0.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
A$34.96 B 31,672.04%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
A$10.70 B 9,628.39%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-A$0.76 Billion-781.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-A$36.48 Million-133.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
A$48.76 M-55.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel